Anthemis Exponential Ventures

"The current pandemic vividly shows the need for digital, non-invasive technologies for clinical diagnosis and monitoring. Clinical trials are on hold, with regulators advising on the use of novel remote endpoints to salvage the trials. At the same time, the shift towards telemedicine models is further accelerating the adoption of digital technologies in the health care sectors. Novoic–with its next generation algorithms and strong focus on clinical validation–is best positioned to drive this acceleration."

"It’s been an incredible privilege to work with such a great team building yulife over the past three years and we’re confident that the further funding will allow us to fulfil our vision of making life insurance a force for good. We’re grateful to receive backing from investors with whom we are so deeply aligned, and believe this will help us promote our proposition to inspire lasting, healthy change in people’s lives."